Source:http://linkedlifedata.com/resource/pubmed/id/12243023
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
2002-9-23
|
| pubmed:commentsCorrections | |
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0177-5537
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
105
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
759-60; author reply 760
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:12243023-Acetamides,
pubmed-meshheading:12243023-Anti-Bacterial Agents,
pubmed-meshheading:12243023-Drug Resistance, Multiple,
pubmed-meshheading:12243023-Humans,
pubmed-meshheading:12243023-Oxazolidinones,
pubmed-meshheading:12243023-Staphylococcal Infections,
pubmed-meshheading:12243023-Staphylococcus aureus
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
[Linezolid in methicillin-resistant staphylococcus aureus infections].
|
| pubmed:publicationType |
Letter,
Comment
|